Advertisement
Review Article| Volume 32, ISSUE 3, P657-670, September 2005

Download started.

Ok

Herpes Simplex Virus in Pregnancy: New Concepts in Prevention and Management

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Perinatology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Fleming D.T.
        • McQuillan G.M.
        • Johnson R.E.
        • et al.
        • (Center for Disease Control and Prevention, Atlanta, Gerorgia; Emory University; Atlanta, Georgia)
        Herpes simplex virus type 2 in the United States, 1976 to 1994.
        N Engl J Med. 1997; 337: 1105-1111
        • Corey L.
        • Handsfield H.H.
        Genital herpes and public health: addressing a global problem.
        JAMA. 2000; 283: 791-794
        • Xu F.
        • Schillinger J.A.
        • Sternberg M.R.
        • et al.
        Seroprevalence and coinfection with herpes simplex virus type 1 and type 2 in the United States, 1988–1994.
        J Infect Dis. 2002; 185: 1019-1024
        • Brown Z.A.
        • Benedetti J.K.
        • Watts D.H.
        A comparison between detailed and simple histories in the diagnosis of genital herpes complicating pregnancy.
        Am J Obstet Gynecol. 1995; 172: 1299-1303
        • Prober C.G.
        • Corey L.
        • Brown Z.A.
        • et al.
        The management of pregnancies complicated by genital infections with herpes simplex virus.
        Clin Infect Dis. 1992; 15: 1031-1038
        • Armstrong G.L.
        • Schillinger J.
        • Markowitz L.
        • et al.
        Incidence of herpes simplex virus type 2 infection in the United states.
        Am J Epidemiol. 2001; 153: 912-920
        • Mertz G.J.
        • Benedetti J.
        • Selke S.A.
        • et al.
        Risk factors for the sexual transmission of genital herpes.
        Ann Intern Med. 1992; 116: 197-202
        • Wald A.
        • Zeh J.
        • Selke S.
        • et al.
        Virologic characteristics of subclinical and symptomatic genital herpes infection.
        N Engl J Med. 1995; 333: 770-775
        • Hensleigh P.A.
        Undocumented history of maternal genital herpes followed by neonatal herpes meningitis.
        J Perinatol. 1994; 14: 216
        • Braig S.
        • Luton D.
        • Sibony O.
        • et al.
        Acyclovir prophylaxis in late pregnancy prevents recurrent genital herpes and viral shedding.
        Eur J Obstet Gynecol Reprod Biol. 2001; 96: 55-58
        • Brown Z.A.
        • Selke S.
        • Zeh J.
        • et al.
        The acquisition of herpes simplex virus during pregnancy.
        N Engl J Med. 1997; 337: 509-515
        • Brown Z.A.
        • Benedetti J.
        • Ashley R.
        • et al.
        Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor.
        N Engl J Med. 1991; 324: 1247-1252
        • Whitley R.J.
        • Hutto C.
        Neonatal herpes simplex virus infections.
        Pediatr Rev. 1985; 7: 119-126
        • Brown Z.A.
        • Wald A.
        • Morrow R.A.
        • et al.
        Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant.
        JAMA. 2003; 289: 203-209
        • Garland S.M.
        • Lee T.N.
        • Sacks S.
        Do antepartum herpes simplex virus cultures predict intrapartum shedding for pregnant women with recurrent disease?.
        Infect Dis Obstet Gynecol. 1999; 7: 230
        • Nahmias A.J.
        • Lee F.K.
        • Beckman-Nahmias S.
        Sero-epidemiological and -sociological patterns of herpes simplex virus infection in the world.
        Scand J Infect Dis Suppl. 1990; 69: 19-36
        • Stone K.M.
        • Brooks C.A.
        • Guinan M.E.
        • et al.
        National surveillance for neonatal herpes simplex virus infections.
        Sex Transm Dis. 1989; 16: 152
        • Sweet R.L.
        • Gibbs R.S.
        Herpes simplex virus infection.
        in: Infectious diseases of the female genital tract. 2nd edition. Williams & Wilkins, Baltimore (MD)1990: 144-157
        • Maccato M.
        Herpes in pregnancy.
        Clin Obstet Gynecol. 1993; 36: 869
        • Straus S.E.
        • Seidlen M.
        • Takeff H.
        Effect of oral acyclovir treatment on symptomatic and asymptomatic virus shedding in recurrent genital herpes.
        Sex Transm Dis. 1989; 16: 107
        • Kroon S.
        Management strategies in herpes: limiting the continued spread of genital herpes. PPS Europe Ltd, Worthing (UK)1994: 17-22
        • Nahass G.T.
        • Goldstein B.A.
        • Zhu W.Y.
        • et al.
        Comparison of Tzanck smear, viral culture, and DNA methods in detection of herpes simplex and varicella-zoster infection.
        JAMA. 1992; 2268: 2541
        • Nahmias A.J.
        • Roizman B.
        Infection with herpes-simplex viruses 1 and 2 (third of three parts).
        N Engl J Med. 1973; 289: 781
        • Cone R.W.
        • Hobson A.C.
        • Huang M.L.W.
        Co-amplified positive control detects inhibition of polymerase chain reactions.
        J Clin Microbiol. 1992; 30: 3185-3189
        • Cone R.W.
        • Swenson P.
        • Hobson A.C.
        • et al.
        Herpes simplex virus detection from genital lesions: a comparative study using antigen detection (HerpCheck) and culture.
        J Clin Microbiol. 1993; 31: 1774-1776
        • Hardy D.A.
        • Arvin A.M.
        • Yasukawa L.L.
        • et al.
        Use of polymerase chain reaction for successful identification of asymptomatic genital infection with herpes simplex virus in pregnant women at delivery.
        J Infect Dis. 1990; 162: 1031-1035
        • Boggess K.A.
        • Watts D.H.
        • Hobson A.C.
        • et al.
        Herpes simplex virus type 2 detection by culture polymerase chain reaction and relationship to genital symptoms and cervical antibody status during the third trimester of pregnancy.
        Am J Obstet Gynecol. 1997; 176: 443-451
        • Brown Z.A.
        • Vontver L.A.
        • Benedetti J.
        • et al.
        Genital herpes in pregnancy: risk factors associated with recurrences and asymptomatic viral shedding.
        Am J Obstet Gynecol. 1985; 24: 153
        • Reeves W.C.
        • Corely L.
        • Adams H.G.
        • et al.
        Risk of recurrence after first episode of genital herpes. Relation to HSV type and antibody response.
        N Engl J Med. 1981; 305: 315
        • Frenkel L.M.
        • Garatty E.M.
        • Shen J.P.
        • et al.
        Clinical reactivation of herpes simplex virus type 2 infection in seropositive women with no history of genital herpes.
        Ann Intern Med. 1993; 118: 414
        • Adler-Storthz K.
        • Dreesman G.R.
        • Kaufman R.H.
        A prospective study of herpes simplex virus infection in a defined population in Houston, Texas.
        Am J Obstet Gynecol. 1985; 151: 582
        • Benedetti J.
        • Corey L.
        • Ashley R.
        Recurrence rates in genital herpes after symptomatic first-episode infection.
        Ann Intern Med. 1994; 121: 847-854
        • Altshuler G.
        Pathogenesis of congenital herpesvirus infection: case report including a description of the placenta.
        Am J Dis Child. 1974; 127: 427-429
        • Chalhub E.F.
        • Baenziger J.
        • Feigen R.D.
        • et al.
        Congenital herpes simplex type II infection with extensive hepatic calcification bone lesions and cataracts: complete postmortem examination.
        Dev Med Child Neurol. 1977; 19: 527-534
        • Monif G.R.
        • Kellner K.R.
        • Donnelly Jr, W.H.
        Congenital herpes simplex type II infection.
        Am J Obstet Gynecol. 1985; 152: 1000-1002
        • American College of Obstetricians and Gynecologists
        Management of herpes in pregnancy. ACOG practice bulletin Number 8. American College of Obstetricians and Gynecologists, Washington (DC)1999
        • Whitley R.J.
        • Corey L.
        • Arvin A.
        • et al.
        Changing presentation of herpes simplex virus infection in neonates.
        J Infect Dis. 1988; 158: 109-116
        • Hutto C.
        • Arvin A.
        • Jacobs R.
        • et al.
        Intrauterine herpes simplex virus infection.
        J Pediatr. 1987; 110: 97-101
        • Corey L.
        • Whitley R.J.
        • Stone E.F.
        • et al.
        Difference in neurologic outcome after antiviral therapy of neonatal central nervous system herpes simplex virus type 1 versus herpes simplex virus type 2 infection.
        Lancet. 1988; 1: 1-4
        • Koskiniemi M.
        • Happonen J.M.
        • Jarvenapaa A.I.
        • et al.
        Neonatal herpes simplex virus infection: a report of 43 patients.
        Pediatr Infect Dis J. 1989; 8: 30-35
        • Sullivan-Bolyai J.Z.
        • Hull H.F.
        • Wilson C.
        • et al.
        Presentation of neonatal herpes simplex virus infections: implications for a change in therapeutic strategy.
        Pediatr Infect Dis J. 1986; 5: 309-314
        • Kohl S.
        A hypothesis on the pathophysiology of neonatal herpes simplex encephalitis: clinical recurrence after asymptomatic primary infection.
        Pediatr Infect Dis J. 1990; 9: 307-308
        • Whitley R.
        • Arvin A.
        • Prober C.
        • et al.
        A controlled trial comparing vidaribine with acyclovir in neonatal herpes simplex virus infection.
        N Engl J Med. 1991; 324: 444-449
        • Growdon W.A.
        • Apodaca L.
        • Cragun J.
        • et al.
        Neonatal herpes simplex virus infection occurring in second twin of an asymptomatic mother. Failure of a modern protocol.
        JAMA. 1987; 257: 508-511
        • Arvin A.M.
        • Hensleigh P.A.
        • Prober C.G.
        • et al.
        Failure of antepartum maternal cultures to predict the infant's risk of exposure to herpes simplex virus at delivery.
        N Engl J Med. 1987; 316: 240-244
        • American College of Obstetricians and Gynecologists
        Perinatal herpes simplex virus infections. ACOG technical bulletin 122. American College of Obstetricians and Gynecologists, Washington (DC)1988
        • Roberts S.W.
        • Cox S.M.
        • Dash J.
        • et al.
        Genital herpes during pregnancy: no lesions, no cesarean.
        Obstet Gynecol. 1995; 85: 261-264
        • Randolph A.G.
        • Washington E.
        • Prober C.G.
        Cesarean delivery for women presenting with genital herpes lesions. Efficacy, risks, and costs [decision analysis].
        JAMA. 1993; 270: 77-82
        • Stray-Pederson B.
        Acyclovir in late pregnancy to prevent neonatal herpes simplex.
        Lancet. 1990; 336: 1594-1595
        • Scott L.L.
        • Sanchez P.J.
        • Jackson G.L.
        • et al.
        Acyclovir suppression to prevent cesarean delivery after first-episode genital herpes.
        Obstet Gynecol. 1996; 87: 69-73
        • Brockelhurst P.
        • Kinghorn G.
        • Carney O.
        • et al.
        A randomized placebo controlled trial of suppressive acyclovir in late pregnancy in women with recurrent genital herpes infection.
        Br J Obstet Gynaecol. 1998; 105: 275-280
        • Watts D.H.
        • Brown Z.A.
        • Money D.
        • et al.
        A double-blind, randomized, placebo-controlled trial of acyclovir in late pregnancy for the reduction of herpes simplex virus shedding and cesarean delivery.
        Am J Obstet Gynecol. 2003; 188: 836-843
        • Sheffield J.S.
        • Hollier L.M.
        • Hill J.B.
        • et al.
        Acyclovir prophylaxis to prevent herpes simplex virus recurrence at delivery: a symptomatic review.
        Obstet Gynecol. 2003; 102: 1396-1403
        • Randolph A.G.
        • Hartshorn R.M.
        • Washington A.E.
        Acyclovir prophyalxis in late pregnancy to prevent neonatal herpes: a cost-effectiveness analysis.
        Obstet Gynecol. 1996; 88: 603-610
        • Centers for Disease Control and Prevention
        Sexually transmitted diseases guidelines.
        MMWR Morb Mortal Wkly Rep. 2002; 51: 1-80
        • Prober C.G.
        Management of the neonate whose mother received suppressive acyclovir therapy during late pregnancy.
        Pediatr Infect Dis J. 2001; 20: 90-91
        • Mertz G.L.
        Epidemiology of genital herpes infections.
        Infect Dis Clin North Am. 1993; 7: 825-839
      1. Andrews W., Kimberlin D., Whitley R.J., et al. Valaciclovir suppressive therapy in pregnant women reduces recurrent genital herpes (HSV): results of a randomized trial. Presented at the 23rd annual meeting of the Society for Maternal-Fetal Medicine. San Francisco, February 3–8, 2003

        • Sheffield J.S.
        • Hill J.
        • Laibl V.
        • et al.
        Valacyclovir suppression to prevent recurrent herpes at delivery: a randomized controlled trial.
        Obstet Gynecol. 2005; 105: 5s
        • Baker D.
        • Brown Z.
        • Hollier L.M.
        • et al.
        Cost-effectiveness of herpes simplex virus type 2 serologic testing and antiviral therapy in pregnancy.
        Am J Obstet Gynecol. 2004; 191: 2074-2084
        • Wittek A.E.
        • Yeager A.S.
        • Au D.S.
        • et al.
        Asymptomatic shedding of herpes simplex virus from the cervix and lesion site during pregnancy. Correlation of antepartum shedding with shedding at delivery.
        Am J Dis Child. 1984; 138: 439-442
        • Reiff-Eldridge R.
        • Heffner C.R.
        • Ephross S.A.
        • et al.
        Monitoring pregnancy outcomes after prenatal drug exposure through prospective pregnancy registries: a pharmaceutical company commitment.
        Am J Obstet Gynecol. 2000; 182: 159-163
        • Klug S.
        • Lewandowski C.
        • Blankenbur G.
        • et al.
        Effect of acyclovir of mammalian embryonic development in culture.
        Arch Toxicol. 1985; 58: 89-96
        • Frenkel L.M.
        • Brown Z.A.
        • Bryson Y.J.
        • et al.
        Pharmacokinetics of acyclovir in the term human pregnancy and neonate.
        Am J Obstet Gynecol. 1991; 164: 569-576
        • Gilstrap L.C.
        • Bawdon R.E.
        • Roberts S.W.
        • et al.
        The transfer of the nucleoside analog ganciclovir across the perfused human placenta.
        Am J Obstet Gynecol. 1994; 170 ([discussion: 972–3]): 967-972
        • Sullender W.M.
        • Miller J.L.
        • Yasukawa L.L.
        • et al.
        Humoral and cell-mediated immunity in neonates with herpes simplex virus infection.
        J Infect Dis. 1987; 155: 28-37
        • Bernstein D.I.
        • Lovett M.A.
        • Bryson Y.J.
        The effects of acyclovir on antibody response to herpes simplex virus in primary genital herpetic infections.
        J Infect Dis. 1984; 150: 7-13
        • Balfour H.H.
        • Rotbart H.A.
        • Feldman S.
        • et al.
        Acyclovir treatment of varicella in otherwise healthy adolescents.
        J Pediatr. 1992; 120: 627-630
        • American College of Obstetricians and Gynecologists
        Gynecologic herpes simplex virus infections. ACOG practice bulletin number 57. American College of Obstetricians and Gynecologists, Washington (DC)2004
        • Elion G.
        • Furman P.A.
        • Fyfe J.A.
        • et al.
        Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine.
        Proc Natl Acad Sci U S A. 1977; 79: 5716-5720
        • Brigden D.
        • Whitman P.
        The clinical pharmacology of acyclovir and its prodrug.
        Scand J Infect Dis. 1985; 47: 33-39
        • Leung D.T.
        • Sacks S.L.
        Current treatment options to prevent perinatal transmission of herpes simplex virus [review].
        Expert Opin Pharmacother. 2003; 4: 1809-1819
        • Corey L.
        • Langenberg A.G.
        • Ashley R.
        • et al.
        Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials.
        JAMA. 1999; 282: 331-340
        • Stanberry L.R.
        • Spruance S.L.
        • Cunningham A.L.
        • et al.
        Glycoprotein-D-adjuvant vaccine to prevent genital herpes.
        N Engl J Med. 2002; 347: 1652-1661
        • White P.J.
        • Garnett G.P.
        Use of antiviral treatment and prophylaxis is unlikely to have a major impact on the prevalence of herpes simplex virus type 2.
        Sex Transm Infect. 1999; 75: 49-54
        • Langenberg A.G.
        • Corey L.
        • Ashley R.L.
        • et al.
        A prospective study of new infections with herpes simplex virus type 1 and type 2.
        N Engl J Med. 1999; 341: 1432-1438
        • Stanberry L.R.
        • Cunningham A.L.
        • Mindel A.
        • et al.
        Prospects for control of herpes simplex virus disease through immunization.
        Clin Infect Dis. 2000; 30: 549-566
        • Deshpande S.P.
        • Kumaraguru U.
        • Rouse B.T.
        Why do we lack an effective vaccine against herpes simplex virus infections?.
        Microbes Infect. 2000; 2: 973-978
        • Garnett G.P.
        • Dubin G.
        • Slaoui M.
        • et al.
        The potential epidemiological impact of a genital herpes vaccine for women.
        Sex Transm Infect. 2004; 80: 24-29
        • Schwartz E.J.
        • Blower S.
        Predicting the potential of individual- and population- level effects of imperfect herpes simplex virus type 2 vaccines.
        J Infect Dis. 2005; 191: 1734-1746